Precision Biosciences (DTIL) Net Margin (2018 - 2026)

Precision Biosciences (DTIL) has 9 years of Net Margin data on file, last reported at 79.12% in Q1 2026.

• On a quarterly basis, Net Margin rose 7327605.0% year-over-year to 79.12% in Q1 2026; TTM through Mar 2026 was 102.05%, a 1336.0% increase from a year earlier, with the FY2025 full-year figure at 2.58%, changed N/A from the prior year.
• Net Margin for Q1 2026 stood at 79.12%, down from 36.23% in the prior quarter.
• Over the last five years, Net Margin for DTIL reached as high as 36.23% in Q4 2025 and fell as low as 212653.85% in Q3 2025.
• Historically, Net Margin has averaged 24729.56% across 5 years, with a median of 112.11% in 2022.
• Across the five-year window, Net Margin plunged 20753857 bps in 2025 and soared 7327605 bps in 2026, its largest moves.
• Year by year, Net Margin stood at 85.5% in 2022, then surged by 53 bps to 40.57% in 2023, then tumbled by 9115 bps to 3738.24% in 2024, then jumped by 101 bps to 36.23% in 2025, then plunged by 318 bps to 79.12% in 2026.
• Per Business Quant data, the three most recent Net Margin figures were 79.12% in Q1 2026, 36.23% in Q4 2025, and 212653.85% in Q3 2025.